Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Procardia XL 60 mg daily vs 30 mg twice daily for hypertension in pregnancy
NCT03595982Phase 4Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Sep 2018
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
A Phase 4 trial of nifedipine in hypertension (HTN), sponsored by Icahn School of Medicine at Mount Sinai. Started Sep 2018; status: terminated.
02
Drugs
nifedipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03595982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03595982.